Unconfigured Ad
Collapse
Any topic/question that does not fit into the subcategories below. If you're unsure of where to put something, ask in here!
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by nilshomer, 05-08-2010, 02:19 PM
|
52 responses
118,242 views
0 reactions
|
Last Post
by archana87
04-23-2019, 01:18 PM
|
||
|
Started by Kat_EdGe, 09-24-2024, 01:16 AM
|
0 responses
172 views
0 reactions
|
Last Post
by Kat_EdGe
09-24-2024, 01:16 AM
|
||
|
Started by Kat_EdGe, 08-26-2024, 01:42 AM
|
0 responses
106 views
0 reactions
|
Last Post
by Kat_EdGe
08-26-2024, 01:42 AM
|
||
|
Started by Kat_EdGe, 08-21-2024, 01:31 AM
|
0 responses
87 views
0 reactions
|
Last Post
by Kat_EdGe
08-21-2024, 01:31 AM
|
||
|
Started by Kat_EdGe, 08-14-2024, 02:30 AM
|
0 responses
94 views
0 reactions
|
Last Post
by Kat_EdGe
08-14-2024, 02:30 AM
|
||
|
Started by yhchin1976, 12-29-2023, 07:06 AM
|
1 response
759 views
1 reaction
|
Last Post
by Noof bk
06-07-2024, 12:23 AM
|
||
|
Started by felipe.iani, 05-20-2024, 05:35 AM
|
1 response
204 views
0 reactions
|
Last Post
by felipe.iani
05-20-2024, 06:09 AM
|
||
|
Started by dr.sharadindu, 04-04-2024, 09:23 PM
|
0 responses
194 views
0 reactions
|
Last Post
|
||
|
Started by Ahmad Salman Sirajee, 03-19-2024, 02:24 AM
|
0 responses
180 views
0 reactions
|
Last Post
|
||
|
Started by Solaezek, 01-12-2024, 12:46 AM
|
1 response
129 views
0 reactions
|
Last Post
by Solaezek
03-17-2024, 08:58 AM
|
||
|
Started by Ashmita Khanal, 02-26-2024, 07:05 PM
|
0 responses
144 views
0 reactions
|
Last Post
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 08-13-2026, 12:22 PM
|
0 responses
27 views
0 reactions
|
Last Post
by SEQadmin2
08-13-2026, 12:22 PM
|
||
|
Started by SEQadmin2, 08-11-2026, 10:35 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
08-11-2026, 10:35 AM
|
||
|
Started by SEQadmin2, 08-06-2026, 07:41 AM
|
0 responses
37 views
0 reactions
|
Last Post
by SEQadmin2
08-06-2026, 07:41 AM
|